<SEC-DOCUMENT>0001104659-21-005882.txt : 20210120
<SEC-HEADER>0001104659-21-005882.hdr.sgml : 20210120
<ACCEPTANCE-DATETIME>20210120164914
ACCESSION NUMBER:		0001104659-21-005882
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210119
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210120
DATE AS OF CHANGE:		20210120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		21539303

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm213709d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;Date of Report (Date of earliest event
reported): January 19, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Applied DNA Sciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: top; width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Delaware</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction<BR> of incorporation)</P></TD><TD STYLE="vertical-align: top; width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>001-36745</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Commission File Number)</P></TD><TD STYLE="vertical-align: top; width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>59-2262718</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices;
zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #231F20">Securities registered pursuant
to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 32%; color: #231F20; text-align: center">Title of each class</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; width: 2%; color: #231F20">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 32%; color: #231F20; text-align: center">Trading <BR> Symbol(s)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; width: 2%; color: #231F20">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 32%; color: #231F20; text-align: center">Name of each exchange on which registered</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Common Stock, $0.001 par value</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">APDN</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">The Nasdaq Capital Market</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter). Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02. Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 19, 2021,
the Board of Directors of Applied DNA Sciences, Inc. (the &ldquo;<U>Company</U>&rdquo;) approved the appointment of Judith Murrah,
62, as the Chief Operating Officer of the Company effective immediately and until the earliest of her removal, termination, or
resignation from such office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ms. Murrah has served
as the Company&rsquo;s Chief Information Officer since June 1, 2013 and as the Company&rsquo;s Secretary since December&nbsp;22,
2017, whereby Ms. Murrah is responsible for both information technology strategy and implementation as well as certain Company
operations. As the Company&rsquo;s Chief Operating Officer, Ms. Murrah will continue to hold the titles of Chief Information Officer
and Secretary, and Ms. Murrah&rsquo;s responsibilities will expand to additional operations functions including the development
of key customer and partner relationships, quality assurance oversight, and operations management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to joining the
Company, Ms. Murrah held leadership positions in the technology industry, including as Senior Director of Information Technology
at Motorola Solutions, and as Vice President for roles within global account sales, corporate and marketing communications, and
information technology at Symbol Technologies before its acquisition by Motorola Solutions. Ms. Murrah holds an MBA from Harvard
Business School and a B.S. in Industrial Engineering from the University of Rhode Island. She is an author of 14 U.S. patents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the Company&rsquo;s
Chief Operating Officer, the Company increased Ms. Murrah&rsquo;s salary to an annual rate of $325,000, effective January 23, 2021,
from $300,000 per annum. Ms. Murrah is not party to an employment agreement with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no other
arrangements or understandings between Ms. Murrah and any other persons pursuant to which Ms. Murrah was appointed as the Company&rsquo;s
Chief Operating Officer. Ms. Murrah does not have any family relationship with any of the Company&rsquo;s directors or executive
officers or any persons nominated or chosen by the Company to be a director or executive officer. Ms. Murrah does not have any
direct or indirect interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation
S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 20, 2021,
the Company issued a press release announcing the appointment of Ms. Murrah as the Chief Operating Officer. A copy of the press
release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01. Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid">Exhibit No.</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid">Description</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 90%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="tm213709d1_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="tm213709d1_ex99-1.htm" STYLE="-sec-extract: exhibit">Press Release dated January 20, 2021</A></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>signatureS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLIED DNA SCIENCES, INC.</B></FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: January 20, 2021</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James A. Hayward</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James A. Hayward</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid">Exhibit No.</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid">Description</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 90%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="tm213709d1_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="tm213709d1_ex99-1.htm" STYLE="-sec-extract: exhibit">Press Release dated January 20, 2021</A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm213709d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm213709d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Applied DNA Promotes Judith Murrah to Chief
Operating Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>STONY BROOK, N.Y. - January 20,
2021 -</B>&nbsp;<U>Applied DNA Sciences, Inc.</U> (NASDAQ: APDN) (the &ldquo;Company&rdquo;), a leader in Polymerase Chain
Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah to the role
of Chief Operating Officer effective immediately. The promotion formalizes Ms. Murrah&rsquo;s expanding range of
responsibilities that includes the development of key customer and partner relationships, QA oversight, and operations
management. Ms. Murrah has been instrumental in the undertaking of capacity expansions for pooled COVID-19 surveillance
testing at the Company&rsquo;s wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC, and for the ongoing
implementation of Current Good Manufacturing Practices (&ldquo;cGMP&rdquo;) at LineaRx, a majority-owned subsidiary of the
Company. The Company believes that the implementation of cGMP at LineaRx is necessary to respond to opportunities in nucleic
acid-based therapeutics &ndash; drugs and biologics &ndash; via the Company&rsquo;s large-scale, PCR-based LinearDNA&trade;
platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Murrah joined Applied
DNA in 2013 as Chief Information Officer and has served as the Company&rsquo;s Secretary since 2017. Prior to joining the Company,
she held leadership positions in the technology industry, including as Senior Director of Information Technology at Motorola Solutions,
and as Vice President for roles within global account sales, corporate and marketing communications, and information technology
at Symbol Technologies before its acquisition by Motorola Solutions. Ms.&nbsp;Murrah holds an MBA from Harvard Business School
and a B.S. in Industrial Engineering from the University of Rhode Island. She is an author of 14 U.S. patents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&quot;This promotion reflects
the confidence of our Board in Judy&rsquo;s leadership ability,&quot; said Dr. James A. Hayward, president, CEO, and chairman,
Applied DNA. &quot;As Chief Information Officer, she demonstrated exceptional judgment and led with energy and a deep commitment
to our core values to drive execution across all of our business groups. We believe her execution on our COVID-19 testing strategy
has us well positioned for continued client base expansion. We look forward to her continued contributions to our growth as Chief
Operating Officer.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms.&nbsp;Murrah is active
in Long Island&rsquo;s business and academic community. She has co-founded and volunteers with non-profits engaging students in
science, technology, engineering, and math disciplines. She serves on the boards of the Middle Country (N.Y.) Library Foundation,
the Tesla Science Center at Wardenclyffe, and Stony Brook University&rsquo;s Center for Corporate Education. Ms.&nbsp;Murrah received
the inaugural 2001 Diamond Award for Long Island Women Leaders in Technology and was named to the 2005 and 2006 list of Top 50
Women of Long Island.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Murrah stated, &ldquo;Applied
DNA's cutting-edge biotechnology platform and markets drive opportunity with a business pace and operational and intellectual&nbsp;demand
that has proven to be a rewarding period in my career. I look forward to continuing to lead and support our innovative, dedicated&nbsp;team
into new opportunities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Applied DNA Sciences </B><BR>
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology,
product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Visit&nbsp;<U>adnas.com</U>&nbsp;for more information. Follow
us on&nbsp;<U>Twitter</U>&nbsp;and&nbsp;<U>LinkedIn</U>. Join our <U>mailing list</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s common stock is listed on NASDAQ under
ticker symbol &lsquo;APDN&rsquo;, and its publicly traded warrants are listed on OTC under ticker symbol &lsquo;APPDW&rsquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Applied DNA is a member of the Russell Microcap&reg; Index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>Forward-Looking Statements<BR>
</B>The statements made by Applied DNA in this press release may be &ldquo;forward-looking&rdquo; in nature within the meaning
of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation
Reform Act of 1995. Forward-looking statements describe Applied DNA&rsquo;s future plans, projections, strategies, and expectations,
and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied
DNA. Actual results could differ materially from those projected due to its history of net losses, limited financial resources,
limited market acceptance, the possibility that the assay kit could become obsolete or have its utility diminished, the uncertainties
inherent in research and development, future clinical data and analysis, including whether any of Applied DNA&rsquo;s or its partner&rsquo;s
diagnostic candidates will advance further in the preclinical research or clinical trial process, including receiving clearance
from the U.S. Food and Drug Administration (U.S. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and
whether and when, if at all, they will receive final approval from the U.S. FDA or equivalent foreign regulatory agencies, the
unknown outcome of any applications or requests to U.S. FDA, equivalent foreign regulatory agencies and/or the New York State
Department of Health, the unknown limited duration of any Emergency Use Authorization (EUA) approval from U.S. FDA, changes in
guidances promulgated by the CDC, U.S. FDA and/or CMS relating to COVID-19 surveillance and diagnostic testing, disruptions in
the supply of raw materials and supplies, and various other factors detailed from time to time in Applied DNA&rsquo;s SEC reports
and filings, including our Annual Report on Form 10-K filed on December 17, 2020, and other reports we file with the SEC, which
are available at&nbsp;www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect
new information, events, or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise
required by law. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor contact: </B>Sanjay M. Hurry, Applied DNA Sciences,
917-733-5573, sanjay.hurry@adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Web:</B>&nbsp;<U>www.adnas.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Twitter: </B>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">###</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm213709d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213709d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  R T@# 2(  A$! Q$!_\0
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M%/AJ:]MM:\._#SQAXOT/0_&=_#>Z;-:W=I'J6G70\-WU_;7%C,ECKETPF0A
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M+5?M_P!BNK6Z@FAF=)HV;\H_V[OVLO!/[0'["'QY\4?L-_\ !2']G7X"Z_\
M#[Q=\,=$\3?M*W?C#1=:\"_#N;5_%F@RW?A+7_$=HNHV_AK4_&FB7D>F:'?1
M6UW<2SW\-E'%'%?&ZA_%W]MSXF?L_?MJ#_@@K\$[=-=^ _\ P3!_:#T&]UG4
M?AY<:RWA32++4?A;9^'O!W@CX-^)-;BU&6SM[;P3Y&H>'=.OSJ,UHH;^W=,G
M=K>UO+7ZR_X+8_L:_LI_L=_\$4OVNO#_ .RK\&? WP?\/>./&_[-.N^*E\$1
MW-P/$NH:7\</AGI>EZUK&JZI?:O>ZA?6NF;8(-5ENI[HJPD8RF1C+\8?9']
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M>?$_]C3XP^#?AQ^U/J'[6OA+]GLR%_$'@?X??$[XB?"#Q/9>"M1DO+"+QO\
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MROP]RA3J*24>1U87N_WD;6E_5&U_MR0A8<D8.,[>N..Q.,'!ZXZ55?6&!/\
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M8]DD^.5PH('AY6(ZC^T..QS_ *DY '.?YU6;X\2JH/\ PCL9)/;4.W/K"/\
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M@[Q[:?8/LVOV\>CZA81W\T7]FVF+?5%O;4B,YA)(( /S _9V_P"#?G]A_P"
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MZ4?$KC!))5LCY(^R<83X.X&LW17+%2E_JA4Q"3UE+FJU'.5I3YFY,\NIX?\
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M "9\3/\ L>VC;_\ BX6HC?\ ]2]9G!ZC'^G=,^N>*@D_8ULY,@_$34QG@_\
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M\,>!9:O(*6FFM?,'^>-9^1[?\$J=+8#_ (OEK@(/4^!]&8?E_:P]NOUJN_\
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M,?\ )+/#Q!/'./\ A(?T^GI7]!'S_P"S^M(0QZD#'IFJ_P"([>+7_1:9DO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
